RNRMarketResearch.com

Acute Ischemic Stroke Therapeutics Market: Increasing Growth Seen in Healthcare Sector by 2021

Press Release   •   Aug 17, 2017 05:25 EDT

This report covers the present scenario and the growth prospects of theGlobal Acute Ischemic Stroke Therapeutics Market for 2017-2021. To calculate the market size, the report considers the sales of branded, generic, and off-label drugs from various drug classes.

The market is divided into the following segments based on geography:

Americas

APAC

EMEA

The analysts forecast Global Acute Ischemic Stroke Therapeutics Market to grow at a CAGR of 2.11% during the period 2017-2021.

Buy copy of the Global Acute Ischemic Stroke Therapeutics Market 2017-2021 report @

http://www.rnrmarketresearch.com/contacts/purchase?rname=1164522

About Acute Ischemic Stroke Therapeutics

AIS is a chronic condition characterized by the sudden loss of blood supply to a part of the brain, thus causing subsequent loss of neurological function. AIS is caused by thrombotic or embolic obstruction of the cerebral artery and is more common than hemorrhagic stroke. The global AIS therapeutics market is expected to register a low single digit market growth during the forecast period. The marginal growth rate is attributed to the lack of approved drugs in this area, the presence of alternative therapies, extensive use of generics, and unmet needs for anticoagulant reversal agents.

This report, Global Acute Ischemic Stroke Therapeutics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years.

Inquire for Discount on the Report at

http://www.rnrmarketresearch.com/contacts/discount?rname=1164522

The report also includes a discussion of the key vendors operating in this market.

Key vendors

Bayer

Boehringer Ingelheim

F. Hoffmann-La Roche

Sanofi

Other prominent vendors

Biogen

Daiichi Sankyo

Pfizer

Market driver

Increasing adoption of NOACs

For a full, detailed list, view our report

Market challenge

Unmet needs for anticoagulant reversal agents

For a full, detailed list, view our report

Market trend

TBI, a value-addition in AIS research

For a full, detailed list, view our report

Major points covered in Global Acute Ischemic Stroke Therapeutics Market 2017 Research are: -

What will the market size be in 2021 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Acute ischemic stroke (AIS): An overview

PART 06: Market landscape

PART 07: Pipeline landscape

PART 08: Market segmentation by drug-class

PART 09: Geographical segmentation

PART 10: Decision framework

PART 11: Drivers and challenges

PART 12: Market trends

PART 13: Vendor landscape

PART 14: Key vendor analysis

PART 15: Appendix

Inquire for this report @

http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=1164522

Contact sales@rnrmarketresearch.com/ Call +1 888 391 5441 for further information on "Global Acute Ischemic Stroke Therapeutics Market 2017-2021” OR for any other market research and intelligence needs you may have for your business.